Verve Therapeutics' gene editing therapy may cure heart attacks once and for all
Bloomberg - 06-May-2022Trials underway to test the safety, but affordability and acceptance of gene therapy are major concerns
Health reporter at Bloomberg
Angelica Peebles is a health reporter at Bloomberg News covering the business of developing and selling prescription drugs, from biotech to pharmacies and other stories in between. Previously, she worked as a health reporter at CNBC.
Angelical completed BS in News-Editorial Journalism from University of Illinois.
Visit website: https://www.bloomberg.com/authors/AUdOq5Fz5GM/angelica-lavito
See alsoDetails last updated 10-May-2022
Trials underway to test the safety, but affordability and acceptance of gene therapy are major concerns